Lantheus Holdings Inc. (NASDAQ:LNTH) shot up 7.3% during mid-day trading on Friday . The company traded as high as $4.80 and last traded at $4.70, with a volume of 188,832 shares. The stock had previously closed at $4.38.

A number of brokerages have issued reports on LNTH. Zacks Investment Research upgraded Lantheus Holdings from a “hold” rating to a “buy” rating and set a $4.75 price target for the company in a research note on Wednesday, June 29th. Jefferies Group reiterated a “buy” rating on shares of Lantheus Holdings in a research note on Wednesday, May 4th. Finally, Robert W. Baird reiterated a “hold” rating on shares of Lantheus Holdings in a research note on Monday, April 11th. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $5.55.

The firm’s 50-day moving average price is $2.91 and its 200 day moving average price is $2.40. The stock’s market capitalization is $152.17 million.

Lantheus Holdings (NASDAQ:LNTH) last released its earnings results on Tuesday, May 3rd. The company reported $0.34 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.06 by $0.28. The business had revenue of $76.50 million for the quarter, compared to analyst estimates of $72.43 million. Equities research analysts forecast that Lantheus Holdings Inc. will post $0.35 EPS for the current year.

A hedge fund recently raised its stake in Lantheus Holdings stock. Numeric Investors LLC raised its position in Lantheus Holdings Inc. (NASDAQ:LNTH) by 42.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 525,258 shares of the company’s stock after buying an additional 156,084 shares during the period. Numeric Investors LLC owned approximately 1.67% of Lantheus Holdings worth $1,775,000 at the end of the most recent quarter.

Lantheus Holdings, Inc is a holding company. The Company, through Lantheus Medical Imaging, Inc, develops, manufactures, sells and distributes diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. It operates in two geographical segments: U.S.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.